A classic antibiotic reimagined: Rationally designed bacitracin variants exhibit potent activity against vancomycin-resistant pathogens.
Proceedings of the National Academy of Sciences of the United States of America
View this publicationProceedings of the National Academy of Sciences of the United States of America
View this publicationACS infectious diseases
View this publicationAntibiotics (Basel, Switzerland)
View this publicationThe ISME journal
View this publicationCell
View this publicationScience advances
View this publicationiScience
View this publicationeLife
View this publicationPLoS pathogens
View this publicationThe Journal of organic chemistry
View this publication